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Abstract
Penicillin-binding proteins (PBPs) are bacterial enzymes involved in the final stages of cell wall
biosynthesis, and are the lethal targets of β-lactam antibiotics. Despite their importance, their roles
in cell wall biosynthesis remain enigmatic. A series of eight substrates, based on variation of the
pentapeptide Boc-L-Ala-γ-D-Glu-L-Lys-D-Ala-D-Ala, were synthesized to test specificity for three
features of PBP substrates: 1) the presence or absence of an Nε-acyl group, 2) the presence of D-
IsoGln in place of γ-D-Glu, and 3) the presence or absence of the N-terminal L-Ala residue. The
capacity of these peptides to serve as substrates for Neisseria gonorrhoeae (NG) PBP3 was assessed.
NG PBP3 demonstrated good catalytic efficiency (2.5 × 105 M−1sec−1) with the best of these
substrates, with a pronounced preference (50-fold) for Nε-acylated substrates over Nε-nonacylated
substrates. This observation suggests that NG PBP3 is specific for the ∼D-Ala-D-Ala moiety of
pentapeptides engaged in cross-links in the bacterial cell wall, such that NG PBP3 would act after
transpeptidase-catalyzed reactions generate the acylated amino group required for its specificity. NG
PBP3 demonstrated low selectivity for γ-D-Glu vs D-IsoGln, and for the presence or absence of the
terminal L-Ala residue. The implications of this substrate specificity of NG PBP3 with respect to its
possible role in cell wall biosynthesis, and for understanding the substrate specificity of the LMM
PBPs in general, are discussed.
Keywords
penicillin-binding protein; peptidoglycan; bacterial cell wall; substrate specificity; peptide substrate;
Neisseria gonorrhoeae
Penicillin-binding proteins (PBPs) are bacterial enzymes that catalyze the final steps in cell
wall biosynthesis, and are the lethal targets of the β-lactam antibiotics (reviewed in (1-6)). The
bacterial cell wall (peptidoglycan or murein) is composed of parallel glycan strands consisting
of a repeating disaccharide, N-acetylglucosamine-β-1,4-N-acetylmuramic acid (NAG-NAM),
in which the N-acetylmuramic acid residues are substituted with a pentapeptide chain. Some
of these peptide chains are cross-linked to other peptide chains from adjacent glycan strands,
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which confer rigidity to the cell wall necessary for cell viability. The structure of the key
pentapeptide building block varies amongst different bacteria, but in Escherichia coli,
Neisseria gonorrhoeae and most other Gram-negative bacteria, the peptide is L-Ala-γ-D-Glu-
m-DAP-D-Ala-D-Ala (m-DAP = meso-diaminopimelic acid). In Gram-negative bacteria, PBPs
catalyze the reactions shown in Figure 1.
Every bacterial species has multiple PBPs, which are generally labeled in order of decreasing
molecular mass. For example, E. coli has eight classically known PBPs, labeled 1A, 1B, and
2-7, as well as several recent additions including PBP1C (7) and PBP6B (8) (recently reviewed
in (9)). PBPs have molecular masses of 20-120 kDa and can be broadly divided into two groups,
the low molecular mass (LMM) PBPs and the high molecular mass (HMM) PBPs. Each of
these groups can be further subdivided into three classes, A, B, and C, based on sequence
analysis (3,10). LMM PBPs are monofunctional enzymes, whereas HMM PBPs possess an
additional domain N-terminal to the PBP domain that in HMM Class A enzymes is a penicillin-
insensitive transglycosylases involved in glycan polymerization of the cell wall. HMM Class
A, B, and C enzymes, as well as LMM Class A and C enzymes, all possess three highly
conserved active site sequence motifs (SXXK, SXN and K(T/S)G), while LMM Class B
enzymes have a YXN in place of the SXN motif. NG PBP3, the subject of the current report,
is a LMM Class C PBP (11).
Different PBPs have different propensities for catalyzing the transpeptidase, hydrolase (DD-
carboxypeptidase), and endopeptidase reactions required for cell wall biosynthesis and
modulation (Fig. 1). For example, HMM PBPs catalyze exclusively transpeptidation reactions,
whereas LMM PBPs catalyze carboxypeptidase (reviewed in (4,5,9,12-14)), endopeptidase
(e.g. EC PBP4 (15-18) and NG PBP3 (11)), and in one case (Streptomyces K15 enzyme)
transpeptidase reactions (19). HMM PBPs are essential for bacterial viability and are the lethal
targets for β-lactam antibiotics, whereas LMM PBPs are non-essential for cell viability. A
particularly enigmatic feature of the PBPs is that LMM PBPs have readily detectible activity
against peptide substrates, whereas purified HMM PBPs have either low or undetectable
activity against natural or synthetic cell wall-related peptide substrates (reviewed in (20)).
Recent studies have made progress in detecting and characterizing the transpeptidase activities
of a few HMM PBPs, such as E. coli PBPs 1A and 1B ((21,22), and references therein), but
these activities are still much lower than those observed with LMM PBPs. The low or
undetectable activity of purified HMM PBPs has been attributed to the regulation of HMM
PBP activity through interactions in macromolecular complexes within the cell wall
environment (5,22-25).
The roles of individual PBPs in bacterial cell wall biosynthesis from a number of bacterial
species have been elucidated by mutagenesis and knockout studies (reviewed in (9,13,26)).
These studies have revealed that HMM PBPs are involved in cell elongation, cell morphology,
and cell division (27). While these studies also show that LMM PBPs are not essential for cell
viability, these PBPs often play important roles in normal bacterial cell morphology (9,26).
Examples of LMM PBPs important for cell morphology include Streptococcus pneumoniae
PBP3 (28,29), Staphylococcus aureus PBP4 (30), E. coli (EC) PBP5 Nelson, 2000 #322;
Nelson, 2001 #206; Nelson, 2002 #205; Ghosh, 2003 #360}, and Neisseria gonorrhoeae (NG)
PBPs 3 and 4 (11). Despite these advances, there remains a significant knowledge gap in
understanding the role of individual PBPs in the cell wall biosynthetic process.
Given their readily detectible activity, most in vitro studies have necessarily focused on LMM
PBPs. Different LMM PBPs show a large range of intrinsic activities against natural and
synthetic cell wall-related substrates (recently reviewed in (14)), with activities ranging from
very weak to nearing the diffusion limit. Despite extensive study, features required for
substrates specificity have been identified only for a few LMM PBPs. For example, the
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Actinomadura R39 enzyme shows a preference for non-Nε-acylated substrates (31,32), and the
Streptomyces R61 LMM PBP has demonstrated a high degree of specificity for a glycine
substituted pimelic acid side chain, with an ε-COOH group analogous to that found in its natural
DAP-containing substrates ((32,33), recently reviewed in (14)).
Neisseria gonorrhoeae are Gram-negative diplococci that are notable for having a relatively
small complement of PBPs (PBPs 1-4), which in principle makes them good models for studies
of PBP function (34-37). NG PBP1 is the gonococcal homolog of E. coli PBP1A and likely
catalyzes both glycan polymerization and transpeptidation during cell growth and elongation
(35), while PBP2 is the gonococcal homolog of E. coli PBP3 and likely functions during cell
division (38). Whereas PBPs 1 and 2 are essential, the LMM PBPs 3 and 4 are not essential
for bacterial survival but do play a role in normal cell morphology (11). NG PBP3 demonstrates
exceptionally high activity (kcat/Km up to 1.8 × 105 M−1 sec−1 ) against simple L-Lys-D-Ala-
D-Ala-based tripeptide substrates (11). Further knowledge of the substrate specificity of NG
PBP3 could provide clues as to its role in gonococcal cell wall biosynthesis, and of the
specificity and role of LMM PBPs in general. To further investigate the substrate specificity
of NG PBP3, a series of eight L-Lys-containing tetra- and pentapeptide substrates were
synthesized and characterized against this enzyme. Our results reveal that NG PBP3 displays
a strong preference for Nε-acylated substrates. The implications of this specificity for the
possible role of NG PBP3 in cell wall biosynthesis, and for understanding the substrate
specificity of the LMM PBPs in general, are discussed.
EXPERIMENTAL PROCEDURES
NG PBP3
NG PBP3 was prepared as described previously (11). Briefly, NG PBP 3 was purified from
E. coli as a fusion protein to maltose-binding protein, digested with TEV protease to cleave
the two proteins, and NG PBP 3 was repurified from the digest. Aliquots were stored at −80 °
C.
Synthesis of substrates
The synthesis and chemical characterization of substrates was performed as described in
Supplemental Data.
DD-Carboxypeptidase activity
PBP DD-carboxypeptidase activity was determined by fluorescence detection of D-Ala using
the Amplex Red-based assay described previously (39,40). PBP assays (50 μL) were performed
in 100 mM pyrophosphate, 100 mM NaCl, 0.5 mg/mL alkylated BSA (Alk-BSA), at pH 8.5.
NG PBP 3 was diluted in assay buffer and added to reactions to start the assays. All assays
were performed at 25 °C in blackwalled microtiter plates. PBP reactions were stopped by the
addition of the detection reagent (150 μL) containing 66.7μg/ml ampicillin (50 μg/mL in 200
μL final assay volume), 13.3 μM AR (10 μM in 200 μL final assay volume), 0.5 units of HRP,
1.67 μg/mL FAD (1.25 μg/mL in 200 μL final assay volume), and 0.015 units DAO in 0.1 M
Tris, pH 8.5. Fluorescence was detected after 90 min development with an excitation
wavelength of 546 nm and emission of 595 nm. Fluorescence was read in a Tecan SpectraFluor
Plus microtiter plate reader (Research Triangle Park, NC). D-Ala standards were included in
each experiment, and blanks were also performed with PBP in the absence of substrate, and
substrate in the absence of PBP.
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Data was processed to obtain v/ET values, and then analyzed by fitting with the appropriate
equation by non-linear regression using SPSS for Windows (Chicago, IL). The form of the
Michaelis-Menten equation shown in Eqn. 1 was used to obtain values and standard errors




For substrates that showed substrate inhibition, only those data points up to the maximally
observed velocity were used for analysis. In such cases the kcat/Km value will be accurate, but
the apparent Km and kcat values will be less than their true values. For substrates that were non-




This study was designed to probe the substrate specificity of NG PBP3 for L-Lys-containing
tetra-peptide (TP) and penta-peptide (PP) substrates. A set of eight substrates were synthesized
and characterized by LCMS and amino acid composition (Supplemental Data). These
substrates were designed to test three features of PBP substrates: 1) the presence or absence of
an Nε-acyl group, 2) the presence of D-IsoGln in place of the γ-D-Glu residue, and 3) the
presence or absence of the N-terminal L-Ala residue. Nε-acylation was considered an important
point of variation, since within the cell wall a given peptidoglycan chain will either be engaged
in a cross-link or not, and this is potentially a key distinguishing feature of PBP specificity.
Another important feature of synthetic substrates is the length of the peptide chain, and
therefore both tetrapeptide and pentapeptide substrates were synthesized as substrates. Finally,
most bacteria use γ-D-Glu in their peptidoglycan, including Neisseria (41, 42), but some
bacterial species use D-IsoGln (or other modified Glu residues) in this position (43), and some
specificity for this feature might be anticipated. γ-D-Glu and D-IsoGln residues were therefore
included in this panel of substrates.
The eight substrates designed to test these three potential sites of NG PBP3 substrate specificity
are illustrated in Figure 2. Note that this set of substrates can be considered as the eight corners
of a cube, with adjacent corners differing by a single substrate feature.
This design was intended to determine if a specific substrate feature gave changes in reactivity
independent of other features, or if there was covariance (interaction) between features. These
eight substrates were examined for their capacity to serve as substrates for NG PBP3, with the
results summarized in Table 1 (note that the compound numbering scheme is based on the
synthetic design, as given in Supplemental Data).
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Since the activity of enzymes frequently varies from one experiment or experimenter to
another, commercially available Ac-L-Lys(Ac)-D-Ala-D-Ala was included as a reference
substrate. In a previous study, a set of Lys Nα- and Nε-substituted L-Lys-D-Ala-D-Ala
tripeptide substrates were characterized against NG PBP3 (11), and the results from this study
are summarized in Table 2 for comparison. Substrate (V) in Table 2 is the reference substrate
Ac-L-Lys(Ac)-D-Ala-D-Ala in Table 1. The variation in enzyme reactivity against Ac-L-Lys
(Ac)-D-Ala-D-Ala (the reference substrate) between Tables 1 and 2 is modest.
NG PBP3 exhibited a pronounced preference for Nε-acylated (+Cbz) substrates ((7-8, 13-14),
Table 1). Peptides lacking an Nε-acyl-capping group ((9-10, 15-16), Table 1) had substantially
less affinity and lower turnover, with substrate (15) showing no turnover. It is important to
note that the specificity of NG PBP3 for Nε-acylated substrates is observed not only with Nε-
Cbz-capped substrates, but also with Ne-acetyl-capped substrates (compare the effect of
acetylation in the tripeptide substrate III in Table 2 vs unacylated tripeptide substrate IV in
Table 2 (11)). Therefore, the observed specificity of NG PBP3 for an Nε-acyl group is not an
artifact of the Cbz capping group. NG PBP3 also demonstrated modestly lower Km and higher
kcat/Km values against pentapeptide substrates (13-16) than against the corresponding
tetrapeptide substrates (7-10). This observation suggests that NG PBP3 forms contacts with
the full length of pentapeptide substrates, but that these contacts contribute only weakly to
binding and turnover. Finally, a slight preference for D-IsoGln peptides (8, 14, 10, 16) over
γ-D-Glu peptides (7, 9, 13, 15) was observed. Within the set of four acylated substrates in Table
1, the presence of γ-D-Glu (7-8) gave substrates without apparent substrate inhibition, whereas
the presence of an IsoGln residue (13-14) was associated with substrate inhibition. It is possible
to quantify these effects by taking the average of the effect of different changes within pairs
of homologous substrates. Since no turnover was observed with substrate (15), pairs with
substrate (15) were excluded from this analysis. For the effect of acylation the kcat/Km ratios
for the substrates were used in the following formula;
Thus, on average, acylation increases catalytic efficiency by a factor of 48-fold. Ratios can
also be calculated for the effect of a longer vs shorter chain (PP vs TP), and of a γ-D-Glu residue
vs a D-IsoGln residue
It is clear that acylation of the Nε-amino group has a pronounced effect on enzyme activity,
while variations in the Gln/Glu residue and the presence or absence of the terminal D-Ala (PP
vs TP) have only slight or modest effects on catalytic efficiency with NG PBP3.
These results can be compared to the result from the study of Pratt and coworkers on the activity
of NG PBP3 against a substrate (JWA3, Fig. 3) designed to include the ε-COOH group of the
DAP residue in natural cell wall substrates of Gram-negative bacteria (Fig. 1) (32,33).
For NG PBP3, a kcat/Km of 10,000 M−1 sec−1 against the m-DAP-based substrate (JWA3) (Fig.
3) was reported (32), which is consistent with the activities observed in this study for the
comparable non-Nε-acylated substrates (Table 1). This observation indicates that NG PBP3
does not require the presence of the ε-COOH group of m-DAP for high activity.
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The substantially higher activity of NG PBP3 with Nε-acylated substrates, which was observed
with both Nε-Cbz-capped substrates (Table 1) and Nε-acetyl-capped substrates from our
previous study of this enzyme (Table 2) (11), is an intriguing result. Within the pool of cell
wall peptides in N. gonorrhoeae, the presence or absence of Nε-acylation is associated with
participation in a cross-link (Fig. 1). The observation of higher activity against Nε-acylated
substrates therefore strongly suggests that NG PBP3 is selective for cross-linked cell wall
pentapeptides. In contrast to Nε-acylation, NG PBP3 shows a lack of specificity for the γ-D-Glu
and L-Ala residues of the pentapeptide backbone, which are static features of the gonococcal
cell wall. In comparison, the Actinomadura R39 PBP instead shows selectivity for substrates
containing a free Nε-amino group (i.e. non-Nε-acylated peptides) (31). Therefore, for NG PBP3
and also for Actinomadura R39 PBP (both LMM Class C PBPs), enzyme specificity appears
focused on acylation or non-acylation respectively of the Nε-amino group of their substrates,
which reflects participation or lack of participation in a cross-link (Fig. 1). Engagement or lack
of engagement in a cross-link is the predominate characteristic that distinguishes subsets of
peptidoglycan chains within bacterial cell walls, and it is logical that some PBPs would have
selectivity for this feature of their natural substrates. It will be of interest for understanding
PBP substrate specificity to determine if similar specificity for acylation status – analogous to
participation in a cross-link – will be apparent in other LMM PBPs such as EC PBP5 (A LMM
Class A PBP), the Streptomyces R61 enzyme (a LMM Class B PBP), or Bacillus subtilis PBP4a
(a LMM Class C PBP). Our own observations with EC PBP5 revealed a lack of specificity
with the Lys-containing substrates shown in Table 1 (unpublished observations), consistent
with the general lack of specificity observed for this enzyme in other studies (reviewed in
(14)). Given that some LMM PBPs require an ε-COOH, most notably the Streptomyces R61
PBP (32,33), it will likely be necessary to test all combinations of these features (e.g. +/− an
amine acceptor acyl group and +/− an ε-COOH group) to obtain a complete picture of the
specificity of a given PBP for this portion of their substrates.
The substrate specificity of NG PBP3 observed here has implications for the possible role of
NG PBP3 in cell wall biosynthesis. A high degree of specificity for Nε-acylated substrates
indicates that NG PBP3 would act after transpeptidation (cross-linking) had occurred (Fig. 4).
Such specificity could serve one or more functions. Transpeptidase reactions, in which one
amide bond is broken and one amide bond is formed (Figure 1), are essentially isoenergetic.
A general principle of metabolism is that essential metabolic processes are driven in the desired
direction by coupling to an exergonic reaction (e.g., hydrolysis of pyrophosphate for ATP −>
AMP + PPi coupled reactions). Although the concentration of D-Ala in the growth environment
is generally expected to be small due to diffusion and recycling of D-Ala, the specificity of NG
PBP3 could provide an additional energetic driving force for transpeptidase reactions by
hydrolyzing the D-Ala-D-Ala bond only on those peptides that had been previously cross-linked
(Fig. 4).
Such an energetic role has previously been suggested for the Streptomyces albus G DD-
carboxypeptidase (a zinc enzyme without sequence homology to the PBP superfamily (44)),
which also has a preference for Nε-acylated substrates (45). Alternatively, the activity of NG
PBP3 could serve to limit the degree of cross-linking within the subset of peptidoglycan peptide
chains upon which it is most active. Deletion mutants of NG PBP3 alone have only a slight
effect on Nesserial cell morphology, although double knockout mutants of both NG PBP3 and
NG PBP4 demonstrate loss of uniformity in cell shape and size and significantly increased
doubling times for growth (11). NG PBP3 therefore does play a role in normal cell shape, and
it seems likely that the specificity of NG PBP3 observed here is somehow involved in this
function.
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The substrate specificity results obtained in this study demonstrate that NG PBP3 exhibits a
pronounced preference for Nε-acylated substrates, and very little preference for features of the
extended pentapeptide chain (L-Ala and γ-D-Glu residues). Comparison with previous studies
indicates that at least one other LMM PBP, the Actinomadura R39 PBP, displays specificity
for Nε-acylation status, although in contrast to NG PBP3, the Actinomadura R39 PBP shows
a preference for non-Nε-acylated substrates. For other LMM PBPs, the presence of the ε-COOH
group of their natural substrates may be required, as demonstrated by Pratt and coworkers for
the Streptomyces R61 enzyme (32,33). These two different features, the presence or absence
of an amine acceptor acyl group and the presence or absence of an ε-COOH group, are clustered
around the acceptor amino group of the Lys/DAP residue in natural bacterial peptidoglycan
(Fig. 1), and this region appears to be the key region for substrate specificity for NG PBP3,
R39, and R61 enzymes, and possibly other LMM PBPs as well. An improved knowledge of
PBP substrate specificity, especially towards specific subsets of natural cell wall peptides, will
be useful for further understanding the role of PBPs in bacterial cell wall biosynthesis, and for
the development of new inhibitors of the PBPs as potential new antibacterial agents.
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Cell wall biosynthesis reactions catalyzed by the PBPs in most Gram-negative bacteria,
including Neisseria gonorrhoeae (41,42) and Actinomadura R39 (46). Cell wall peptides are
attached to a repeating NAG-NAM polysaccharide. Variations in the peptide substrate, such
as substitution of L-Lys and other diamine acids in place of m-DAP, are often observed in Gram-
positive bacteria (reviewed in (43)). In Gram-negative bacteria a cross-link is formed directly
between the Nε of the acyl group acceptor and the D-Ala carboxyl group of the acyl group donor,
whereas in many Gram-positive bacteria a bridging amino acid or short peptide (interpeptide
bridge) is found. For example, Streptomycs R61 has a Gly interpeptide bridge attached to the
Nε-amino group of L,L-DAP (47). PBPs attack the cell wall peptide to release D-Ala and form
an acyl-enzyme intermediate (the acyl group donor). The acyl group can either be hydrolyzed
(+H2O) (hydrolase/DD-carboxypeptidase activity) or transferred to the acceptor amino group
on an adjacent cell wall peptide (right to left down diagonal arrow) to form a cross-link
(transpeptidase activity). Cross-linked peptides are also cleaved by PBPs (endopeptidase
activity, left to right up diagonal arrow).
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Structures of and relationships between the substrates used in this study.
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Structure of the pimelic acid-based substrate used by Anderson et al. with NG PBP3 (32).
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A possible role for NG PBP3 in peptidoglycan biosynthesis based on its specificity for acylated
pentapeptide substrates. NG PBP3 catalyzed reactions would follow transpeptidase catalyzed
cross-linking reactions, which generate a substrate suitable for NG PBP3's substrate specificity.
A transpeptidase reaction is essentially isoenergetic, whereas a carboxypeptidase reaction
releases the energy of a peptide bond. If appropriately coupled to the peptidoglycan
biosynthesis process, NG PBP3 could conceivably energetically drive gonococcal
peptidoglycan biosynthesis.
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Table 2








Boc-L-Lys(Cbz)-D-Ala-D-Ala (I) 3.3 (0.8)* 580 (60)* 180,000 (30,000)
Ac-L-Lys(Cbz)-D-Ala-D-Ala (II) 3.7 (0.2)* 530 (10)* 142,000 (6,000)
Boc-L-Lys(Ac)-D-Ala-D-Ala (III) 6.5 (0.8) 400 (10) 62,000 (6,000)
Boc-L-Lys-D-Ala-D-Ala (IV) 32 (3)* 260 (10)* 8,300 (400)
Ac-L-Lys(Ac)-D-Ala-D-Ala (V) 19 (2) 550 (20) 29,000 (2,000)
Ac-L-Lys(Ac)-D-Ala-D-Lac (VI) 28 (3) 340 (20) 12,300 (800)
*
Substrate inhibition observed.
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